Dr. Cheedella is board-certified in internal medicine, specializing in hematology, and medical oncology. She is now part of NEXT Dallas as a Phase 1 clinical investigator.
Shiraj Sen, MD, PhD
Dr. Shiraj Sen is a medical oncologist and director of NEXT Oncology Dallas. Meeting some of the first individuals with cancer treated on modern immunotherapy clinical trials and watching them feel better and live longer after being told that there were no further standard treatments for them to receive motivated him to pursue a career in drug development in order …
Sharon T. Wilks, MD, FACP
Dr. Sharon T. Wilks is a valuable member of the Phase 1 Clinical Investigation Team. She focuses on research and advancement in the treatment of breast cancer with more than 32 years of research and clinical experience as a hematologist and medical oncologist. Dr. Wilks has been involved in breast cancer research since her early career in the Air Force. …
Ildefonso Ismael Rodriguez, M.D.
Medical Oncologist and Clinical Investigator Dr. Rodriguez is a Phase 1 clinical investigator at NEXT Oncology in San Antonio, Texas. He is board-certified in internal medicine, hematology, and medical oncology. He leads multiple clinical trials at NEXT and is thrilled to offer clinical trial options for the diverse community of San Antonio. One of his goals is to expand patient …
Andrae Vandross, M.D.
Dr. Andrae Vandross is trained, and board certified in medical oncology and internal medicine. He leads the Phase 1 clinical trial group at NEXT Oncology in Austin. Dr. Vandross is experienced in comprehensive and clear discussions with advanced cancer patients who are navigating the complex decisions associated with novel therapeutics. His highest priority is patient education in the context of …
David Sommerhalder, M.D.
Dr. David Sommerhalder specializes in and is board certified in medical oncology and hematology and is also board certified in internal medicine. He works at NEXT Oncology San Antonio as an investigator on numerous clinical trials, where he helps to find additional treatment options for patients who otherwise may be out of options. He does this with the ultimate goal …
